Patents Assigned to CV Molecular Therapeutics, Inc.
  • Peptides and their use to ameliorate cell death
    Patent number: 7115562
    Abstract: The present invention relates to a method of reducing cell death in a warm-blood animal wherein said cell death associated with a neurodegenerative disorder, an immune disease, a neoplastic disorder, an inflammatory disorder, or a viral disease. The method comprises administering to said animal a therapeutically effective amount of a peptide comprising amino acid sequence: Ser-Val-Asp-Val-Glu-Tyr.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: October 3, 2006
    Assignee: CV Molecular Therapeutics, Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Peptides and their use to ameliorate cell death
    Patent number: 6841532
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: January 11, 2005
    Assignee: CV Molecular Therapeutics, Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Peptides and their use to ameliorate cell death
    Patent number: 6348567
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: April 19, 1999
    Date of Patent: February 19, 2002
    Assignee: CV Molecular Therapeutics Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin